Application 021411
- Type
- NDA
- Sponsor
- LILLY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 5MG | No | No |
| 002 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 10MG | Yes | No |
| 003 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 18MG | Yes | No |
| 004 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 25MG | Yes | No |
| 005 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 40MG | Yes | No |
| 006 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 60MG | Yes | Yes |
| 007 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 80MG | Yes | No |
| 008 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 100MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021411-001 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | 2002-11-26 | ||
| N021411-002 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | |
| N021411-003 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | |
| N021411-004 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | |
| N021411-005 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | |
| N021411-006 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | |
| N021411-007 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2005-02-14 | |
| N021411-008 | STRATTERA | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2005-02-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021411-001 | STRATTERA | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | 2002-11-26 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N021411-002 | STRATTERA | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021411-003 | STRATTERA | EQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021411-004 | STRATTERA | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021411-005 | STRATTERA | EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021411-006 | STRATTERA | EQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2002-11-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021411-007 | STRATTERA | EQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2005-02-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021411-008 | STRATTERA | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2005-02-14 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Strattera | ATOMOXETINE HYDROCHLORIDE | Eli Lilly and Company | 309de576-c318-404a-bc15-660c2b1876fb | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 021411 NDA021411 0002-3238 0002-3251 0002-3239 0002-3229 0002-3228 0002-3250 0002-3227 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0002-3227 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3227 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3227 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3227 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3228 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3228 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3228 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3228 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3229 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3229 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3229 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3229 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3238 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3238 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3238 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3238 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3239 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3239 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3239 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3239 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3250 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3250 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3250 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3250 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3251 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3251 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3251 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 0002-3251 | Strattera | Atomoxetine hydrochloride | Eli Lilly and Company | NDA | Current |
| 49999-636 | Strattera | Atomoxetine | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 64725-3228 | Strattera | Atomoxetine hydrochloride | TYA Pharmaceuticals | NDA | Current |
| 66993-040 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-040 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-040 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-040 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-041 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-041 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-041 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-042 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-042 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-042 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-042 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-043 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-043 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-043 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-043 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-044 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-044 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-044 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-044 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-045 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-045 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-045 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-045 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-046 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-046 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-046 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-046 | Atomoxetine | Atomoxetine hydrochloride | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 68151-4484 | Strattera | Atomoxetine hydrochloride | Carilion Materials Management | NDA | Current |
| 68151-4485 | Strattera | Atomoxetine hydrochloride | Carilion Materials Management | NDA | Current |
| 68151-4486 | Strattera | Atomoxetine hydrochloride | Carilion Materials Management | NDA | Current |
| 68151-4487 | Strattera | Atomoxetine hydrochloride | Carilion Materials Management | NDA | Current |
| 68151-4488 | Strattera | Atomoxetine hydrochloride | Carilion Materials Management | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69821 | SUPPL | 2022-01-07 |
| 69820 | SUPPL | 2022-01-07 |
| 69819 | SUPPL | 2022-01-07 |
| 61971 | SUPPL | 2020-02-26 |
| 61970 | SUPPL | 2020-02-26 |
| 61960 | SUPPL | 2020-02-26 |
| 48504 | SUPPL | 2017-05-24 |
| 48486 | SUPPL | 2017-05-22 |
| 48485 | SUPPL | 2017-05-22 |
| 15411 | SUPPL | 2015-05-29 |
| 27717 | SUPPL | 2015-05-28 |
| 15412 | SUPPL | 2015-04-21 |
| 5304 | SUPPL | 2015-04-20 |
| 27716 | SUPPL | 2014-02-21 |
| 15409 | SUPPL | 2014-02-21 |
| 5303 | SUPPL | 2013-12-09 |
| 15410 | SUPPL | 2013-12-05 |
| 27715 | SUPPL | 2013-08-06 |
| 5302 | SUPPL | 2013-08-06 |
| 15408 | SUPPL | 2013-08-05 |
| 15407 | SUPPL | 2013-08-05 |
| 36860 | SUPPL | 2012-09-12 |
| 27714 | SUPPL | 2012-08-20 |
| 15404 | SUPPL | 2012-07-10 |
| 5299 | SUPPL | 2012-07-09 |
| 15406 | SUPPL | 2012-06-18 |
| 5301 | SUPPL | 2012-06-18 |
| 5300 | SUPPL | 2011-03-10 |
| 15405 | SUPPL | 2011-03-07 |
| 15403 | SUPPL | 2010-07-31 |
| 27713 | SUPPL | 2010-07-30 |
| 27712 | SUPPL | 2009-06-16 |
| 27711 | SUPPL | 2009-06-16 |
| 36859 | SUPPL | 2009-06-04 |
| 15402 | SUPPL | 2009-06-04 |
| 36858 | SUPPL | 2008-07-29 |
| 36857 | SUPPL | 2008-07-29 |
| 15401 | SUPPL | 2008-07-29 |
| 27710 | SUPPL | 2008-07-25 |
| 5298 | SUPPL | 2008-07-25 |
| 5297 | SUPPL | 2008-07-25 |
| 44642 | SUPPL | 2008-07-17 |
| 5292 | SUPPL | 2008-05-09 |
| 36856 | SUPPL | 2007-10-04 |
| 5295 | SUPPL | 2007-10-04 |
| 21642 | SUPPL | 2007-07-06 |
| 36855 | SUPPL | 2007-05-01 |
| 36854 | SUPPL | 2007-05-01 |
| 36853 | SUPPL | 2007-05-01 |
| 36852 | SUPPL | 2007-05-01 |
| 27707 | SUPPL | 2007-05-01 |
| 27703 | SUPPL | 2007-05-01 |
| 15400 | SUPPL | 2007-05-01 |
| 5296 | SUPPL | 2007-05-01 |
| 5294 | SUPPL | 2007-05-01 |
| 5293 | SUPPL | 2007-05-01 |
| 27709 | SUPPL | 2006-10-23 |
| 15399 | SUPPL | 2006-10-23 |
| 27708 | SUPPL | 2005-11-18 |
| 23656 | ORIG | 2005-09-30 |
| 27704 | SUPPL | 2005-05-27 |
| 27705 | SUPPL | 2005-02-17 |
| 27706 | SUPPL | 2005-02-03 |
| 5291 | SUPPL | 2005-02-03 |
| 42142 | ORIG | 2003-03-07 |
| 36851 | SUPPL | 2003-01-17 |
| 27702 | SUPPL | 2003-01-17 |
| 15398 | ORIG | 2002-11-26 |
| 5290 | ORIG | 2002-11-26 |